Novel missense mutation in ALS2 gene results in infantile ascending hereditary spastic paralysis

Ann Neurol. 2006 Jun;59(6):976-80. doi: 10.1002/ana.20879.

Abstract

Objective: Recessive mutations in ALS2 (juvenile amyotrophic lateral sclerosis) are causative for early-onset upper motor neuron diseases, including infantile ascending hereditary spastic paralysis (IAHSP). The goal of this study is to identify novel disease-causing ALS2 mutations.

Methods: Mutations in ALS2 were screened by direct sequencing of complementary DNA obtained from patients' lymphoblasts.

Results: We report a novel ALS2 missense mutation in patients affected by IAHSP. This homozygous G669A mutation in exon 4 is predicted to result in a tyrosine substitution at cysteine 156 of the RCC1 (regulator of chromatin condensation)-like domain, encoding a putative guanine exchange factor for Ran guanosine triphosphatase, leading to a loss of ALS2 function due to instability of mutant protein.

Interpretation: These results highlight the important role of the RCC1-like domain in ALS2 stability and function that is essential for upper motor neuron maintenance.

Publication types

  • Case Reports
  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Base Sequence
  • Blotting, Western
  • Cell Cycle Proteins / genetics
  • DNA Mutational Analysis
  • Female
  • Guanine Nucleotide Exchange Factors / genetics*
  • Humans
  • Molecular Sequence Data
  • Mutation, Missense*
  • Nuclear Proteins / genetics
  • Pedigree
  • Sequence Homology, Nucleic Acid
  • Spastic Paraplegia, Hereditary / genetics*

Substances

  • ALS2 protein, human
  • Cell Cycle Proteins
  • Guanine Nucleotide Exchange Factors
  • Nuclear Proteins
  • RCC1 protein, human